• 1
    Hafler DA, Slavik JM, Anderson DE, O’Connor KC, De Jager P, Baecher-Allan C. Multiple sclerosis. Immunol Rev 2005; 204:20831.
  • 2
    McQualter JL, Bernard CC. Multiple sclerosis: a battle between destruction and repair. J Neurochem 2007; 100:295306.
  • 3
    Riley-Vargas RC, Gill DB, Kemper C, Liszewski MK, Atkinson JP. CD46: expanding beyond complement regulation. Trends Immunol 2004; 25:496503.
  • 4
    Kemper C, Atkinson JP. T-cell regulation: with complements from innate immunity. Nat Rev Immunol 2007; 7:918.
  • 5
    Russell S. CD46: a complement regulator and pathogen receptor that mediates links between innate and acquired immune function. Tissue Antigens 2004; 64:1118.
  • 6
    Marie JC, Astier AL, Rivailler P, Rabourdin-Combe C, Wild TF, Horvat B. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat Immunol 2002; 3:65966.
  • 7
    Astier AL, Hafler DA. Abnormal Tr1 differentiation in multiple sclerosis. J Neuroimmunol 2007; 191:708.
  • 8
    Astier AL, Meiffren G, Freeman S, Hafler DA. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest 2006; 116:32527.
  • 9
    Liszewski MK, Post TW, Atkinson JP. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol 1991; 9:43155.
  • 10
    Manchester M, Gairin JE, Patterson JB, Alvarez J, Liszewski MK, Eto DS, Atkinson JP, Oldstone MB. Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2. Virology 1997; 233:17484.
  • 11
    Buchholz CJ, Koller D, Devaux P, Mumenthaler C, Schneider-Schaulies J, Braun W, Gerlier D, Cattaneo R. Mapping of the primary binding site of measles virus to its receptor CD46. J Biol Chem 1997; 272:220729.
  • 12
    Liszewski MK, Tedja I, Atkinson JP. Membrane cofactor protein (CD46) of complement. Processing differences related to alternatively spliced cytoplasmic domains. J Biol Chem 1994; 269:107769.
  • 13
    Manchester M, Liszewski MK, Atkinson JP, Oldstone MB. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc Natl Acad Sci USA 1994; 91:21615.
  • 14
    Johnstone RW, Russell SM, Loveland BE, McKenzie IF. Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Mol Immunol 1993; 30:123141.
  • 15
    Johnstone RW, Russell S, Loveland BE, McKenzie IF. Tissue-specific expression of CD46 protein isoforms due to production of RNA splice variants. Transplant Proc 1994; 26:1248.
  • 16
    Purcell DF, Russell SM, Deacon NJ, Brown MA, Hooker DJ, McKenzie IF. Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation. Immunogenetics 1991; 33:33544.
  • 17
    Xing PX, Russell S, Prenzoska J, McKenzie I. Discrimination between alternatively spliced STP-A and -B isoforms of CD46. Immunology 1994; 83:1227.
  • 18
    Seya T, Atkinson JP. Functional properties of membrane cofactor protein of complement. Biochem J 1989; 264:5818.
  • 19
    Longhi MP, Harris CL, Morgan BP, Gallimore A. Holding T cells in check – a new role for complement regulators? Trends Immunol 2006; 27:1028.
  • 20
    Elward K, Griffiths M, Mizuno M, Harris CL, Neal JW, Morgan BP, Gasque P. CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J Biol Chem 2005; 280:3634254.
  • 21
    Kavanagh D, Richards A, Atkinson JP. Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med 2008; 59:293309.
  • 22
    Richards A, Kemp EJ, Liszewski MK et al. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A 2003; 100:1296671.
  • 23
    Noris M, Brioschi S, Caprioli J, Todeschini M, Bresin E, Porrati F, Gamba S, Remuzzi G. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 2003; 362:15427.
  • 24
    Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 2000; 287:498501.
  • 25
    Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993; 75:295305.
  • 26
    Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C, Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993; 67:602532.
  • 27
    Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000; 406:8937.
  • 28
    Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin DE. Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996; 273:22831. Published erratum appears in Science 1997; 275:1053.
  • 29
    Kurita M, Yanagi Y, Hara T, Nagasawa S, Matsumoto M, Seya T. Human lymphocytes are more susceptible to measles virus than granulocytes, which is attributable to the phenotypic differences of their membrane cofactor protein (CD46). Immunol Lett 1995; 48:915.
  • 30
    Schnorr JJ, Xanthakos S, Keikavoussi P, Kampgen E, Ter Meulen V, Schneider-Schaulies S. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci U S A 1997; 94:532631.
  • 31
    Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell 1999; 99:81727.
  • 32
    Greenstone HL, Santoro F, Lusso P, Berger EA. Human herpesvirus 6 and Measles virus employ distinct CD46 domains for receptor function. J Biol Chem 2002; 277:391128.
  • 33
    Smith A, Santoro F, Di Lullo G, Dagna L, Verani A, Lusso P. Selective suppression of IL-12 production by human herpesvirus 6. Blood 2003; 102:287784.
  • 34
    Segerman A, Atkinson JP, Marttila M, Dennerquist V, Wadell G, Arnberg N. Adenovirus type 11 uses CD46 as a cellular receptor. J Virol 2003; 77:918391.
  • 35
    Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003; 9:140812.
  • 36
    Giannakis E, Jokiranta TS, Ormsby RJ et al. Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46). J Immunol 2002; 168:458592.
  • 37
    Okada N, Liszewski MK, Atkinson JP, Caparon M. Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci U S A 1995; 92:248993.
  • 38
    Kallstrom H, Liszewski MK, Atkinson JP, Jonsson AB. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol 1997; 25:63947.
  • 39
    Johansson L, Rytkonen A, Bergman P et al. CD46 in meningococcal disease. Science 2003; 301:3735.
  • 40
    Cattaneo R. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens’ magnet. J Virol 2004; 78:43858.
  • 41
    Takemoto M, Yamanishi K, Mori Y. Human herpesvirus 7 infection increases the expression levels of CD46 and CD59 in target cells. J Gen Virol 2007; 88:141522.
  • 42
    Kallstrom H, Islam MS, Berggren PO, Jonsson AB. Cell signaling by the type IV pili of pathogenic Neisseria. J Biol Chem 1998; 273:2177782.
  • 43
    Yant S, Hirano A, Wong TC. Identification of a cytoplasmic Tyr-X-X-Leu motif essential for down regulation of the human cell receptor CD46 in persistent measles virus infection. J Virol 1997; 71:76670.
  • 44
    Astier A, Trescol-Biemont MC, Azocar O, Lamouille B, Rabourdin-Combe C. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J Immunol 2000; 164:60915.
  • 45
    Hirano A, Kurita-Taniguchi M, Katayama Y, Matsumoto M, Wong TC, Seya T. Ligation of human CD46 with purified complement C3b or F(ab′)2 of monoclonal antibodies enhances isoform-specific interferon gamma-dependent nitric oxide production in macrophages. J Biochem 2002; 132:8391.
  • 46
    Lee SW, Bonnah RA, Higashi DL, Atkinson JP, Milgram SL, So M. CD46 is phosphorylated at tyrosine 354 upon infection of epithelial cells by Neisseria gonorrhoeae. J Cell Biol 2002; 156:9517.
  • 47
    Kurita-Taniguchi M, Fukui A, Hazeki K et al. Functional modulation of human macrophages through CD46 (measles virus receptor): production of IL-12 p40 and nitric oxide in association with recruitment of protein-tyrosine phosphatase SHP-1 to CD46. J Immunol 2000; 165:514352.
  • 48
    Fernandez-Centeno E, De Ojeda G, Rojo JM, Portoles P. Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. J Immunol 2000; 164:453342.
  • 49
    Gaglia JL, Mattoo A, Greenfield EA, Freeman GJ, Kuchroo VK. Characterization of endogenous Chinese hamster ovary cell surface molecules that mediate T cell costimulation. Cell Immunol 2001; 213:8393.
  • 50
    Jimenez-Perianez A, Ojeda G, Criado G, Sanchez A, Pini E, Madrenas J, Rojo JM, Portoles P. Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts. J Leukoc Biol 2005; 78:138696.
  • 51
    Rooney IA, Heuser JE, Atkinson JP. GPI-anchored complement regulatory proteins in seminal plasma. An analysis of their physical condition and the mechanisms of their binding to exogenous cells. J Clin Invest 1996; 97:167586.
  • 52
    Zaffran Y, Destaing O, Roux A, Ory S, Nheu T, Jurdic P, Rabourdin-Combe C, Astier AL. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J Immunol 2001; 167:67805.
  • 53
    Oliaro J, Pasam A, Waterhouse NJ, Browne KA, Ludford-Menting MJ, Trapani JA, Russell SM. Ligation of the cell surface receptor, CD46, alters T cell polarity and response to antigen presentation. Proc Natl Acad Sci U S A 2006; 103:1868590.
  • 54
    Ludford-Menting MJ, Oliaro J, Sacirbegovic F et al. A network of PDZ-containing proteins regulates T cell polarity and morphology during migration and immunological synapse formation. Immunity 2005; 22:73748.
  • 55
    Ludford-Menting MJ, Thomas SJ, Crimeen B, Harris LJ, Loveland BE, Bills M, Ellis S, Russell SM. A functional interaction between CD46 and DLG4: a role for DLG4 in epithelial polarization. J Biol Chem 2002; 277:447784.
  • 56
    Thompson C, Powrie F. Regulatory T cells. Curr Opin Pharmacol 2004; 4:40814.
  • 57
    Paust S, Cantor H. Regulatory T cells and autoimmune disease. Immunol Rev 2005; 204:195207.
  • 58
    Bluestone JA, Tang Q. How do CD4+CD25+ regulatory T cells control autoimmunity? Curr Opin Immunol 2005; 17:63842.
  • 59
    Sakaguchi S, Powrie F. Emerging challenges in regulatory T cell function and biology. Science 2007; 317:6279.
  • 60
    Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor foxp3. Science 2003; 299:105761.
  • 61
    Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006; 212:2850.
  • 62
    Faria AM, Weiner HL. Oral tolerance. Immunol Rev 2005; 206:23259.
  • 63
    Xystrakis E, Kusumakar S, Boswell S et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006; 116:14655.
  • 64
    Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4(+) cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421:38892.
  • 65
    Price JD, Schaumburg J, Sandin C, Atkinson JP, Lindahl G, Kemper C. Induction of a regulatory phenotype in human CD4+ T cells by streptococcal M protein. J Immunol 2005; 175:67784.
  • 66
    Grossman WJ, Verbsky JW, Tollefsen BL, Kemper C, Atkinson JP, Ley TJ. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 2004; 104:28408.
  • 67
    Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004; 21:589601.
  • 68
    Haas J, Hug A, Viehover A et al. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol 2005; 35:334352.
  • 69
    Huan J, Culbertson N, Spencer L et al. Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res 2005; 81:4552.
  • 70
    Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199:9719.
  • 71
    Vaknin-Dembinsky A, Murugaiyan G, Hafler DA, Astier AL, Weiner HL. Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. J Neuroimmunol 2008; doi: 10.1016/j.jneuroim.2008.01.002.
  • 72
    Soldan SS, Berti R, Salem N et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997; 3:13947.
  • 73
    Alvarez-Lafuente R, Garcia-Montojo M, De las Heras V, Bartolome M, Arroyo R. Clinical parameters and HHV-6 active replication in relapsing–remitting multiple sclerosis patients. J Clin Virol 2006; 37 (Suppl. 1):S246.